Molecule Information
General Information of the Molecule (ID: Mol01133)
Name |
Undecaprenyl-diphosphatase BcrC (BCRC)
,Bacillus subtilis
|
||||
---|---|---|---|---|---|
Synonyms |
Undecaprenyl pyrophosphate phosphatase; ywoA; BSU36530
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
bcrC
|
||||
Gene ID | |||||
Sequence |
MNYEIFKAIHGLSHHNSVLDSIMVFITEYAIVAYALILLAIWLFGNTQSRKHVLYAGITG
IAGLVINYLITLVYFEPRPFVAHTVHTLIPHAADASFPSDHTTGALAISIAMLFRNRKIG WPLVIFGLLTGFSRIWVGHHYPVDVLGSLVVAIIIGFLFFRFSDLLRPFVDLVVRIYEAI INKLTKKPTDQNF Click to Show/Hide
|
||||
Function |
Catalyzes the dephosphorylation of undecaprenyl diphosphate (UPP). Confers resistance to bacitracin.
Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
ADTT: Aberration of the Drug's Therapeutic Target
Drug Resistance Data Categorized by Drug
Approved Drug(s)
3 drug(s) in total
Bacitracin A
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Bacillus subtilis infection | [1] | |||
Resistant Disease | Bacillus subtilis infection [ICD-11: 1G40.1] | |||
Resistant Drug | Bacitracin A | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Escherichia coli C41(DE3) | 469008 | ||
Escherichia coli DH5alpha | 668369 | |||
Bacillus subtilis 168 | 224308 | |||
Bacillus subtilis BFS82 | 1423 | |||
Bacillus subtilis BSmrs168 | 1423 | |||
Bacillus subtilis BSmrs173 | 1423 | |||
Bacillus subtilis BSmrs175 | 1423 | |||
Bacillus subtilis BSmrs194 | 1423 | |||
Bacillus subtilis BSmrs201 | 1423 | |||
Escherichia coli Ecmrs144 | 562 | |||
Escherichia coli Ecmrs150 | 562 | |||
Escherichia coli Ecmrs151 | 562 | |||
Experiment for Molecule Alteration |
PCR amplification and DNA sequence assay | |||
Experiment for Drug Resistance |
Microtiter tray assay | |||
Mechanism Description | Overexpression of the BcrCBs protein, formerly called YwoA, in Escherichia coli or in Bacillus subtilis allows these bacteria to stand higher concentrations of bacitracin. |
Bacitracin F
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Bacillus subtilis infection | [1] | |||
Resistant Disease | Bacillus subtilis infection [ICD-11: 1G40.1] | |||
Resistant Drug | Bacitracin F | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Escherichia coli C41(DE3) | 469008 | ||
Escherichia coli DH5alpha | 668369 | |||
Bacillus subtilis 168 | 224308 | |||
Bacillus subtilis BFS82 | 1423 | |||
Bacillus subtilis BSmrs168 | 1423 | |||
Bacillus subtilis BSmrs173 | 1423 | |||
Bacillus subtilis BSmrs175 | 1423 | |||
Bacillus subtilis BSmrs194 | 1423 | |||
Bacillus subtilis BSmrs201 | 1423 | |||
Escherichia coli Ecmrs144 | 562 | |||
Escherichia coli Ecmrs150 | 562 | |||
Escherichia coli Ecmrs151 | 562 | |||
Experiment for Molecule Alteration |
PCR amplification and DNA sequence assay | |||
Experiment for Drug Resistance |
Microtiter tray assay | |||
Mechanism Description | Overexpression of the BcrCBs protein, formerly called YwoA, in Escherichia coli or in Bacillus subtilis allows these bacteria to stand higher concentrations of bacitracin. |
Bacitracin methylene disalicylate
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Bacillus subtilis infection | [1] | |||
Resistant Disease | Bacillus subtilis infection [ICD-11: 1G40.1] | |||
Resistant Drug | Bacitracin methylene disalicylate | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Escherichia coli C41(DE3) | 469008 | ||
Escherichia coli DH5alpha | 668369 | |||
Bacillus subtilis 168 | 224308 | |||
Bacillus subtilis BFS82 | 1423 | |||
Bacillus subtilis BSmrs168 | 1423 | |||
Bacillus subtilis BSmrs173 | 1423 | |||
Bacillus subtilis BSmrs175 | 1423 | |||
Bacillus subtilis BSmrs194 | 1423 | |||
Bacillus subtilis BSmrs201 | 1423 | |||
Escherichia coli Ecmrs144 | 562 | |||
Escherichia coli Ecmrs150 | 562 | |||
Escherichia coli Ecmrs151 | 562 | |||
Experiment for Molecule Alteration |
PCR amplification and DNA sequence assay | |||
Experiment for Drug Resistance |
Microtiter tray assay | |||
Mechanism Description | Overexpression of the BcrCBs protein, formerly called YwoA, in Escherichia coli or in Bacillus subtilis allows these bacteria to stand higher concentrations of bacitracin. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.